CollPlant and CELLINK will explore the use of CELLINK's next-generation high throughput extrusion bioprinters for the future commercial production of CollPlant's regenerative breast implants, addressing a $2.8 Bn market
PR Newswire
GOTHENBURG, Sweden and REHOVOT, Israel, Feb. 16, 2022